GENTING HIGHLANDS, Malaysia, July 30, 2024 /PRNewswire/ — Renowned for its vibrant entertainment and leisure offerings, Genting Highlands is rapidly emerging as a prime destination for property investment in 2024. This region promises substantial rental returns, making it an irresistible choice for discerning investors. With its unique blend of high demand, robust commercial activity, and promising […]
Category Archives: Pr Newswire
New capabilities target energy, construction, and manufacturing sectors for improved efficiency and cost savings. BERGEN, Norway, July 30, 2024 /PRNewswire/ — Dataloy Systems has introduced major upgrades to its Voyage Management System (VMS), aimed at revolutionising charter operations within the energy, construction, and manufacturing sectors. These enhancements are designed to increase logistical flexibility, reduce costs, […]
Key Takeaways A GLP-1 agonist — the class of drugs shown to help with diabetes and weight loss and reduce the risk of heart disease — also may protect the brain. In a Phase 2b trial, liraglutide appears to reduce shrinking in the parts of the brain that control memory, learning, language and decision-making by […]
DUBAI, UAE, July 30, 2024 /PRNewswire/ — The Dubai International Financial Centre (DIFC), the leading global financial centre in MEASA region, announced outstanding results for the first half of 2024. Coinciding with its 20th anniversary, the results reinforce DIFC’s growing role in driving the future of finance, and Dubai’s position as a top global ecosystem for […]
SHENZHEN, China, July 30, 2024 /PRNewswire/ — With the rapid advancement of AI technology, toys, one of humanity’s greatest inventions driven by natural instincts, are now encountering new development opportunities. On June 25th, emerging AI toy innovator Haivivi officially launched the world’s first interactive talking toy based on AIGC technology—BubblePal. Leveraging its cutting-edge AI technology and […]
30
Jul
Jul
TORONTO, July 29, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement offering of 400,000 common shares priced at $1.50 per common share (the “Common Shares”) for gross proceeds of $600,000 CAD (the “Offering”). The proceeds of the […]
Pr Newswire
Earth Science Tech, Inc., Reports its June 30, 2024, Quarter Results, Recording Over $8.5M in Revenue and $1.07M in Net Profit
30
Jul
Jul
Miami, FL, July 29, 2024 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a holding entity currently focused on the health and wellness industry, today shares its financial results from its quarter ended June 30, 2024. For the three-month quarter ended June 30, 2024, the Company recorded: $1,384,407 in Cash, versus $91,989 […]
30
Jul
Jul
IRVINE, Calif., July 29, 2024 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on […]
Pr Newswire
Bionomics to Provide a Corporate Update and Discuss End-of-Phase 2 Meeting Outcomes on the Development of BNC210 in PTSD on July 31, 2024
30
Jul
Jul
ADELAIDE, Australia and CAMBRIDGE, Mass., July 29, 2024 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced that it will provide a corporate update and […]
30
Jul
Jul
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024 Mont-Saint-Guibert, Belgium – July 29, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), […]